Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Merck Serono and Domain Therapeutics join to develop agents for Parkinson's disease

Jan. 18, 2011

Galapagos provides update on arthritis alliance with GSK

Jan. 18, 2011

Epizyme and GSK join to develop agents targeting histone methyltransferases

Jan. 18, 2011

Lilly and Boehringer Ingelheim enter global diabetes alliance

Jan. 18, 2011

Dyax and Sigma-Tau expand agreement to commercialize Kalbitor

Jan. 17, 2011

Celtic Therapeutics acquires RX-10045 from Resolvyx Pharma

Jan. 17, 2011

AstraZeneca and SCRI join to develop targeted anticancer agent

Jan. 13, 2011

Seattle Genetics and Pfizer join to develop anticancer antibody-drug conjugates

Jan. 12, 2011

Bristol-Myers Squibb and Pharmasset to evaluate combination treatment for chronic hepatitis C

Jan. 12, 2011

Immutep and GSK enter into agreement for ImmuTune IMP-731

Jan. 12, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...